0.00
-0.0005(-25.00%)
Currency In CHF
Address
Siriusdreef 17
Hoofddorp, 2132 WT
Netherlands
Phone
31 23 568 9494
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
1
First IPO Date
December 20, 2018
| Name | Title | Pay | Year Born |
| Mr. Vinvcenzo Moccia | Chief Executive Officer, Executive Director & Interim Chief Financial Officer | 0 | 1960 |
| Nicola Mona | Chief Executive Officer & Director | 0 | N/A |
| Pierpaolo Cerani | Chief Executive Officer & Director | 0 | N/A |
| Mr. Pierpaolo Cerani | Chief Executive Officer & Executive Director | 0 | N/A |
| Mr. Diego Fiorentini | Chief Financial Officer | 0 | 1972 |
| Ms. Rosanna Squitti | Research Director and Head of R&D | 0 | 1968 |
IGEA Pharma N.V. commercializes health-tech and med-tech products and devices in in the United States and the Netherlands. It offers Alz1, an at-home lab test kit to measure non-bound copper in the blood; dietary supplement products to reduce blood heavy metals content under the Alz1 Tab brand; and COVID19 rapid test for the detection of IgM and IgG SARS-CoV-2 related antibodies. The company also provides dry aerosol generators for air and inanimate environmental surfaces sanitization, as well as air sterilization and purification devices. In addition, it engages in laboratory analysis. The company was incorporated in 2015 and is headquartered in Hoofddorp, the Netherlands.